Again and Again, a company invested by Infinity Capital, has passed the IPO examination!

On July 24, the 17th Issuance Review Committee of China Securities Regulatory Commission released the announcement of the 108th Issuance Review Committee meeting in 2018. Wuxi Lihu Booster Technology Co., Ltd. (hereinafter referred to as "Lihu Holding") was approved in the first round, which means Lihu Holding has taken a key step towards the goal of A-share listing, and this is also the fifth IPO-approved enterprise invested by Infinity Capital in the past two years.  

Lihu was established in 1994, mainly engaged in research and development, manufacturing and sales of impellers, turbines, precision castings and turbochargers. Self-management and agency of import and export of various commodities and technologies. At present, Lihu have 54 patents for inventions and 74 patents for utility models, and are key high-tech enterprises in China Torch Program.

In recent years, Lihu's research and development capability, production management, quality control, and timely delivery capability have been widely recognized by customers. It has won honorary certificates such as "Gold Award for Timely Delivery at Global Supplier Conference" awarded by Honeywell and "Excellent Supplier" awarded by Mitsubishi Industries. Its matching engines are widely used in BMW, Audi, Volkswagen, General Motors, Toyota, Honda, Ford, and other major global automobile brands. The Infinity Yangzhou Fund injected 25 million yuan into Lihu, injecting capital strength into its rapid development in recent years. At the same time, it gave key guidance during the listing process of Lihu and helped its IPO preparation in an all-round way.

According to the relevant person from Infinity Capital, investing in Lihu is an important measure taken by Infinity to insist on capital to help the industry take off. The listing of Lihu will bring rich returns to investors. It will also prove Infinity's keen sense of industry and accurate investment vision and become another excellent investment case in China.  

As a well-known international investment management institution with Israeli ancestry, Infinity Equity Management Limited was established in 2004 and is the first Israeli investment fund to enter China. In June 2015, Zhuhai Huafa Group became a shareholder and an important strategic partner of Infinity Capital. With the support of Huafa Group, the mode of "introducing innovative technologies into cross-border capital investment" adopted by Infineon Capital has further won the trust and support of governments and partners in all parts of China. The company has managed a fund of over 3.8 billion yuan and has made key arrangements in the fields of health care, life sciences, energy conservation and environmental protection, precision manufacturing and new materials. In the last two years, Vincent Medical (HK01612), AsymChem (002821), Huati Technology (603679) and Liancheng Precision (002921) have been successfully listed. Golden Point Garden, Hongtu Separator and IOPtima have been acquired by listed companies Meishang Ecology (300495), Jinguan Electric (300510) and Kanghong Pharmaceutical (002773), respectively, with good results. At present, there are still a number of invested companies running on the road to the IPO examination of the CSRC.

At the same time, Infinity Capital has also given full play to its channel and resource advantages in Israel, hosting fourth China-Israel Technology Innovation Investment Summit since 2016, making positive contributions to promoting innovation and pragmatic cooperation between China and Israel. In particular, the third and fourth congresses jointly hosted with Huafa Group in Zhuhai received strong support from the state, Guangdong Province and Zhuhai City. They successfully attracted more than 5,000 innovative enterprises and more than 10,000 guests from China and Israel to participate in the conference and reached a cooperation number of billions of US dollars. They became the largest scientific and technological innovation exchange activities since the establishment of diplomatic relations between China and Israel and injected new vitality and vigor into the promotion of the construction of "the belt and road initiative" and the scientific and technological innovation cooperation between China and Israel.

In the future, Infinity Capital will continue to adhere to the prudent and professional investment philosophy to help the invested enterprises to continue to grow and grow and to create long-term rich returns with lower risks for shareholders and investors. We will continue to play the role of a bridge and link between China and Israel, explore high-quality innovation resources from a global perspective, and help Chinese enterprises integrate deeply into the global science and technology innovation network.